Jose A. Marin-Mata

Cmn
Unidad Del Seguro Social En Santa Fe, DIF, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Effectiveness and safety of dolutegravir/lamivudine/abacavir versus bictegravir/emtricitabine/tenofovir alafenamide as first-line regimens in real-world settings (MICTLAN study).

Effectiveness and safety of dolutegravir/lamivudine/abacavir versus bictegravir/emtricitabine/tenofovir alafenamide as first-line regimens in real-world settings (MICTLAN study).

Journal: International journal of STD & AIDS

Published: November 18, 2025

Clinical and microbiological profile of invasive Salmonella disease in Mexico: a single-center retrospective study.

Clinical and microbiological profile of invasive Salmonella disease in Mexico: a single-center retrospective study.

Journal: BMC infectious diseases

Published: October 07, 2025

Metabolomic Profile of Weight Gain of People Living with HIV Treated with Integrase Strand Transfer Inhibitor Regimens Reveals Dysregulated Lipid Metabolism and Mitochondrial Dysfunction.

Metabolomic Profile of Weight Gain of People Living with HIV Treated with Integrase Strand Transfer Inhibitor Regimens Reveals Dysregulated Lipid Metabolism and Mitochondrial Dysfunction.

Journal: Metabolites

Published: September 14, 2025

Genotypes and Risk Factors for Anal Cytological Abnormalities in People Living With HIV and High-Risk Human Papillomavirus: The GAIA 2 Study Cytological Abnormalities in People Living With HIV and High-Risk Human Papillomavirus.

Genotypes and Risk Factors for Anal Cytological Abnormalities in People Living With HIV and High-Risk Human Papillomavirus: The GAIA 2 Study Cytological Abnormalities in People Living With HIV and High-Risk Human Papillomavirus.

Journal: Cytopathology : official journal of the British Society for Clinical Cytology

Published: August 29, 2025

Prevalence and Risk Factors of Latent Tuberculosis Infection Detected by IGRA in Patients with Immune-Mediated Inflammatory Diseases Before and During Biologic DMARD Therapy (TITAN Study).

Prevalence and Risk Factors of Latent Tuberculosis Infection Detected by IGRA in Patients with Immune-Mediated Inflammatory Diseases Before and During Biologic DMARD Therapy (TITAN Study).

Journal: Journal of clinical medicine

Published: June 04, 2025

Prevalence and Associated Factors for HPV in People Living with HIV: Are INSTIs Protective Against HPV-16? The GAIA Study.

Prevalence and Associated Factors for HPV in People Living with HIV: Are INSTIs Protective Against HPV-16? The GAIA Study.

Journal: Viruses

Published: June 02, 2025

Integrase strand transfer inhibitors, their impact in adipose tissue and weight gain in people living with HIV - A narrative review.

Integrase strand transfer inhibitors, their impact in adipose tissue and weight gain in people living with HIV - A narrative review.

Journal: Nutricion hospitalaria

Published: May 06, 2025

High Prevalence of Asymptomatic STIs in MSM PWH in a Male HIV Clinic in Mexico City.

High Prevalence of Asymptomatic STIs in MSM PWH in a Male HIV Clinic in Mexico City.

Journal: Journal of the International Association of Providers of AIDS Care

Published: February 19, 2025

Prevalence and Risk Factors of Occult HCV Infection in the Adult Population of Mexico City.

Prevalence and Risk Factors of Occult HCV Infection in the Adult Population of Mexico City.

Journal: Viruses

Published: January 09, 2025

Incidence of metabolic syndrome in people with HIV who start dolutegravir based-regimen compared with bictegravir based-regimen after 48 weeks.

Incidence of metabolic syndrome in people with HIV who start dolutegravir based-regimen compared with bictegravir based-regimen after 48 weeks.

Journal: AIDS (London, England)

Published: November 26, 2024

Incidence of non-alcoholic fatty liver disease in antiretroviral therapy-naïve people with human immunodeficiency virus who start DTG/ABC/3TC compared to BIC/FTC/TAF at 48-week follow-up.

Incidence of non-alcoholic fatty liver disease in antiretroviral therapy-naïve people with human immunodeficiency virus who start DTG/ABC/3TC compared to BIC/FTC/TAF at 48-week follow-up.

Journal: International journal of STD & AIDS

Published: September 27, 2024

Challenges and Opportunities for Adult Vaccine Coverage: Insights for Healthcare Professionals Focusing on Herpes Zoster in Mexico.

Challenges and Opportunities for Adult Vaccine Coverage: Insights for Healthcare Professionals Focusing on Herpes Zoster in Mexico.

Journal: Vaccines

Published: September 26, 2024

Showing 1-12 of 50

Last Updated: 09/26/2026